Lactobacillus reuteri DSM 17938 and Reduced Abdominal Pain

• Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?

  • 2021-06-23
  • Systematic Review
  • Medicina 57(7)
  • • A. Saviano
    • M. Brigida
    • A. Migneco
    • Gayani Gunawardena
    • C. Zanza
    • M. Candelli
    • F. Franceschi
    • V. Ojetti

  • PubMed: 34201542
  • DOI: 10.3390/medicina57070643

  10 Insights on

  • Reduced Abdominal Pain

  • High evidence
  • Rigorous Journal

  Improves abdominal pain in patients with colitis or inflammatory bowel disease.

  Effect

  Beneficial

  Effect size

  Moderate

• Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.

  • 2018-01-29
  • RCT · n = 56
  • Beneficial Microbes 9(1)
  • • G. Riezzo
    • A. Orlando
    • B. D’Attoma
    • M. Linsalata
    • M. Martulli
    • F. Russo

  • PubMed: 29022390
  • DOI: 10.3920/BM2017.0049

  4 Insights on

  • Reduced Abdominal Pain

  • High evidence

  the beneficial effect of LR DSM 17938 compared to placebo was significantly evident for symptoms related to gas content and dysbiosis (abdominal discomfort, pain and bloating)

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes

  Dose

  2×10^8 to 4×10^8 CFU/day